Biocellular-Cellular Regenerative Treatment Scaring Alopecia and Alopecia Areata

Exclusion criteria

• . Subjects who have used oral spironolactone, finasteride, dutasteride, minoxidil, or any oral or topical medication including over the counter and herbal medications for the treatment of hair loss within 12 months of study screening.
• . Simultaneous treatment with an investigational product or procedure within 30 days, or planned future participation in another clinical study
• . Subject has previously failed or has been deemed non-responsive to a previous experimental hair loss treatment.
• . Subject must have no recent PRP, biocellular treatments, micro needling, cold laser therapies, or any other scalp or hair loss treatment.
• . Subject with previously diagnosed or suspected unspecified dermatologic condition, or disorders that will make hair growth difficult (such as systemic burns, etc.).
• . History of or active diagnosis of systemic autoimmune disease or organ transplantation or immunosuppressive medication(s).
• . Receiving active cancer treatment or have present or previous malignancies except a history of squamous or basal skin cell carcinoma with excision for cure.
• . Active systemic infection at the time of enrollment. If acquired afterwards, exclusion based on clinical judgment of investigator.